SCHEMBL7143239

SCHEMBL7143239

CCN(CC)CCCCCOC1CCN(C(C=O)c2ccc(F)cc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LSS P48449 2/20 0.46
ALDH1A1 P00352 1/20 0.34
GHSR Q92847 1/20 0.34
BCHE P06276 3/20 0.33
ACHE P22303 2/20 0.33
CHRM2 P08172 2/20 0.33
CHRM1 P11229 2/20 0.33
CYP3A4 P08684 2/20 0.33
CHRM3 P20309 1/20 0.33
HTR1A P08908 1/20 0.33
ADRA2A P08913 1/20 0.33
DRD1 P21728 1/20 0.33
SLC6A2 P23975 1/20 0.33
ADRA1A P35348 1/20 0.33
OPRM1 P35372 1/20 0.33
DRD3 P35462 1/20 0.33
SLC6A3 Q01959 1/20 0.33
KCNH2 Q12809 1/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7141801 0.87 LSS (0.62) LSSSLC6A2SLC6A3KCNH2CYP2D6
SCHEMBL7143566 0.85 LSS (0.49) LSSSLC6A2SLC6A3KCNH2CYP2D6
SCHEMBL7139755 0.84 LSS (0.65) LSS
SCHEMBL8057772 0.75 LSS (0.53) LSS
SCHEMBL6450181 0.74 LSS (0.56) LSSALDH1A1BCHEACHECYP3A4
SCHEMBL7146640 0.73 LSS (0.52) LSS
SCHEMBL27580069 0.72 LSS (0.43) LSSALDH1A1BCHEACHECHRM2
SCHEMBL7147061 0.70 LSS (0.42) LSSCHRM2ADRA2AADRA1ADRD3
SCHEMBL7145438 0.69 LSS (0.45) LSSBCHEACHECHRM2ADRA2A
SCHEMBL7142595 0.66 LSS (0.44) LSSCHRM2ADRA2AADRA1ADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1317432-A1 PIPERIDINE DERIVATIVES FOR USE AS 2,3-OXIDOSQUALENE-LANOSTEROL CYCLASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2003-06-11 EP disclosed
WO-2002020483-A1 PIPERIDINE DERIVATIVES FOR USE 2,3-OXIDOSQUALENE-LANOSTEROL CYCLASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2002-03-14 WO disclosed